Ampio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.com

Analysts at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report issued on Saturday. The firm set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

NYSE AMPE opened at $0.00 on Friday. The stock has a market cap of $2,497.00, a PE ratio of 0.00 and a beta of 3.49. Ampio Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $7.47.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.